Who founded Curavit Clinical Research?

Curavit Clinical Research was founded by Joel Morse in 2019.

Who are Curavit Clinical Research's investors?

Curavit Clinical Research's investors include Osage Venture Partners.

How much funding has Curavit Clinical Research raised?

Curavit Clinical Research has disclosed $11.4M raised across 1 round.

Where is Curavit Clinical Research headquartered?

Curavit Clinical Research is headquartered in Scarsdale, US.

Curavit Clinical Research

Scarsdale, US · Founded 2019 · Delaware corporation · 49 employees on LinkedIn · 1 known investors

Find your way into Curavit Clinical Research

102 people in our graph share verified history with the Curavit Clinical Research team — schools, employers, funds. One of them is your warm intro.

Roger Krakoffunlockedknows Joel Morse · together at Tufts University (overlapped)

×8knows the team · via Columbia University

×2knows the team · via Tufts University

knows the team · via C3i Solutions

Curavit is a contract research organization (CRO) that designs and runs decentralized clinical trials for trial sponsors, using its Virtual Clinical Site platform alongside broader CRO services. It focuses on digital, remote-first clinical research aimed at speeding timelines and improving data quality and participant experience.

Biotech Digital Health Healthtech

Founders & leadership

Curavit Clinical Research was founded in 2019 by Joel Morse.

Joel Morse inFounderJoel Morse is an executive with experience in healthcare business development, operations, and team leadership, including roles starting ventures, raising financing, and managing global organizations.

David HanamanNamed on SEC filing

Board

Jackie KentBoard director

Rich LesterBoard director

Nathanael LentzBoard directorGeneral Partner at Osage Venture Partners

Investors · 1

Osage Venture PartnersBala Cynwyd · $500K – $3M

Reported raises · per SEC filings

Form D private placements

$11.4M disclosed across 1 round · 2022

▶$11.4MraisedSep 2024 · 30 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jackie KentDirector
Rich LesterDirector
Joel MorseExecutive Officer, Director
Nathanael LentzDirector
David HanamanDirector

Offering amount: $11.6M
Amount sold: $11.4M
First sale: Sep 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Changing the Face—and Faces—of Clinical Research - Curavit Clinical Researchcuravit.io · Mar 2024

Curavit Raises $5 Million in Series A Funding to Accelerate Growth in Digital Therapeutics Clinical Researchprnewswire.com · Nov 2022

Press - Curavit Clinical Researchcuravit.io · Aug 2021

Frequently asked questions

What does Curavit Clinical Research do?: Curavit is a contract research organization (CRO) that designs and runs decentralized clinical trials for trial sponsors, using its Virtual Clinical Site platform alongside broader CRO services. It focuses on digital, remote-first clinical research aimed at speeding timelines and improving data quality and participant experience.
Who founded Curavit Clinical Research?: Curavit Clinical Research was founded by Joel Morse in 2019.
Who are Curavit Clinical Research's investors?: Curavit Clinical Research's investors include Osage Venture Partners.
How much funding has Curavit Clinical Research raised?: Curavit Clinical Research has disclosed $11.4M raised across 1 round.
Where is Curavit Clinical Research headquartered?: Curavit Clinical Research is headquartered in Scarsdale, US.